The global stem cell market reached over $5.9 billion in 2015 and will grow from about $6.7 billion in 2016 to nearly $12.3 billion in 2021, registering a compound annual growth rate (CAGR) of 13.1% from 2016 through 2021.
This report provides:
An overview of the global market for stem cells and related technologies
Analyses of global market trends, with data from 2014, 2015, estimates for 2016 and projections of compound annual growth rates (CAGRs) through 2021
Information on the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market
A look at the regulatory environment, healthcare policies, demographics, and other factors directly affecting stem cell-related markets
Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities
Examination of strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market
Profiles of major players in the industry
SCOPE OF REPORT
This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.